Evidence map›Paper›PMID 24567447›Full record

ArticleThe Journal of experimental medicine2014

Real-time immune cell interactions in target tissue during autoimmune-induced damage and graft tolerance.

Jason Miska, Midhat H Abdulreda, Priyadharshini Devarajan, Jen Bon Lui, Jun Suzuki, Antonello Pileggi, Per-Olof Berggren, Zhibin Chen

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 2 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 2 syntheses or guidelines pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Article
  7. Treg cells require Izumo1R to regulate γδT cell-driven inflammation in the skin.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Functional analysis of islet cells in vitro, in situ, and in vivo.Seminars in cell & developmental biology · 2020
    Review
  18. Pancreatic islets engineered with a FasL protein induce systemic tolerance at the induction phase that evolves into long-term graft-localized immune privilege.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 2 countries.

Jason MiskaDepartment of Microbiology and Immunology and 2 Department of Surgery, 3 Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL 33136 4 Department of Biomedical Engineering, University of Miami, Coral Gables, FL 33124.
Midhat H Abdulreda
Priyadharshini Devarajan
Jen Bon Lui
Jun Suzuki
Antonello Pileggi
Per-Olof Berggren
Zhibin Chen
University of Miami · US

Funding

Virginia Mason/UCHSC Autoimmune Prevention CenterU19AI050864 · NIAID · UNIVERSITY OF COLORADO DENVER · PI EISENBARTH, GEORGE S · 2001 to 2011
$29.2M
Multi-Disciplinary Approaches to Driving Therapeutic Human Beta Cell ReplicationU01DK089538 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI STEWART, ANDREW F. · 2010 to 2014
$3.6M
The quantitative biology of CTLA4 splice variants in T1DDP3DK085696 · NIDDK · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI CHEN, ZHIBIN · 2009 to 2009
$2.3M
Role of macrophages in pancreatic islet graft rejectionK01DK097194 · NIDDK · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ABDULREDA, MIDHAT H · 2013 to 2015
$415k
Noninvasive two-photon imaging of pancreatic islet graft rejection in the eyeF32DK083226 · NIDDK · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ABDULREDA, MIDHAT H · 2009 to 2011
$151k
NIAID NIH HHS 5U19AI050864-10NIAID NIH HHS U19 AI050864NIDDK NIH HHS DP3 DK085696NIDDK NIH HHS DP3DK085696NIDDK NIH HHS F32 DK083226NIDDK NIH HHS F32DK083226NIDDK NIH HHS K01 DK097194NIDDK NIH HHS NIH-U-01DK089538NIDDK NIH HHS U01 DK089538
6 · The paper itself

Abstract

Real-time imaging studies are reshaping immunological paradigms, but a visual framework is lacking for self-antigen-specific T cells at the effector phase in target tissues. To address this issue, we conducted intravital, longitudinal imaging analyses of cellular behavior in nonlymphoid target tissues to illustrate some key aspects of T cell biology. We used mouse models of T cell-mediated damage and protection of pancreatic islet grafts. Both CD4(+) and CD8(+) effector T (Teff) lymphocytes directly engaged target cells. Strikingly, juxtaposed β cells lacking specific antigens were not subject to bystander destruction but grew substantially in days, likely by replication. In target tissue, Foxp3(+) regulatory T (Treg) cells persistently contacted Teff cells with or without involvement of CD11c(+) dendritic cells, an observation conciliating with the in vitro "trademark" of Treg function, contact-dependent suppression. This study illustrates tolerance induction by contact-based immune cell interaction in target tissues and highlights potentials of tissue regeneration under antigenic incognito in inflammatory settings.

Indexed as

Adoptive TransferAnalysis of VarianceAnimalsAutoantigensAutoimmunityBromodeoxyuridineCell CommunicationCrosses, GeneticFluorescenceImage Processing, Computer-AssistedIslets of Langerhans TransplantationMiceMice, Inbred C57BLMice, TransgenicRNA InterferenceT-Lymphocytes, RegulatoryAutoantigensBromodeoxyuridine

Identifiers

PMID24567447
PMCPMC3949570
OpenAlexW2169032921

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.